Thoughts on Fluoroquinolones in Resistant Pneumococcal Meningitis

Neyzi O Ertuğrul T Darendeliler F. Pediatrics. 5th ed. Istanbul, Turkey: Nobel Medical Publishing; 2020.

Hudson JA Broad J Martin NG , et al Outcomes beyond hospital discharge in infants and children with viral meningitis: a systematic review. Rev Med Virol. 2020;30(2):e2083.

Nakamura T Cohen AL Schwartz S , et al The global landscape of pediatric bacterial meningitis data reported to the WHO-coordinated vaccine-preventable disease surveillance network, 2014–2019. J Infect Dis. 2021;224(12, suppl 2):S161-S173.

van de Beek D Cabellos C Dzupova O , et al ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016;22(suppl 3):S37-62.

Li L Ma J Yu Z Li M Zhang W Sun H. Epidemiological characteristics and antibiotic resistance mechanisms of Streptococcus pneumoniae: an updated review. Microbiol Res. 2023;266:127221.

Kim KS. Acute bacterial meningitis in infants and children. Lancet Infect Dis. 2010;10(1):32-42.

World Health Organization. Pocket Book of Hospital Care for Children: Guidelines for the Management of Common Childhood Illnesses. 2nd ed. 2025 update. Geneva, Switzerland: WHO; 2025.

Tunkel AR Hartman BJ Kaplan SL , et al Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39:1267-1284.

Miner JR Heegaard W Mapes A Biros M. Time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center. J Emerg Med. 2001;21(4):387-392.

Alamarat Z Hasbun R. Management of acute bacterial meningitis in children. Infect Drug Resist. 2020;13:4077-4089.

Lee HY Wu TL Su LH , et al Invasive pneumococcal disease caused by ceftriaxone-resistant Streptococcus pneumoniae in Taiwan. J Microbiol Immunol Infect. 2018;51(4):500-509.

Barichello T Generoso JS Simões LR , et al Role of antibiotics in the neuromodulation of experimental pneumococcal meningitis. J Neural Transm. 2016;123(6):671-679.

Eisen DP Hogg GG. Empirical treatment of bacterial meningitis. Med J Aust. 1993;158(10):681-685.

Cottagnoud P Täuber MG. Fluoroquinolones in the treatment of meningitis. Curr Infect Dis Rep. 2003;5:329.

Hameed N Tunkel AR. Treatment of drug-resistant pneumococcal meningitis. Curr Infect Dis Rep. 2010;12(4):274-281.

Kanellakopoulou K Pagoulatou A Stroumpoulis K , et al Pharmacokinetics of moxifloxacin in non-inflamed CSF of humans: implications for bactericidal effect. J Antimicrob Chemother. 2008;61(6):1328-1331.

Sáez-Llorens X McCoig C Feris JM , et al Quinolone treatment for pediatric bacterial meningitis: a comparative study of trovafloxacin and ceftriaxone with or without vancomycin. Pediatr Infect Dis J. 2002;21:14.

Rodriguez-Cerrato V McCoig CC Michelow IC , et al Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coliç meningitis. Antimicrob Agents Chemother. 2001;45(11):3092-3097.

Ishikawa K Matsuo T Suzuki T Kawai F Uehara Y Mori N. Penicillin- and third-generation cephalosporin-resistant strains of Streptococcus pneumoniae meningitis: case report and literature review. J Infect Chemother. 2022;28(5):663-668.